Get a glimpse into our company and investor data—powered by the PitchBook Platform
Swift Molecular Diagnostics
Accelerator/IncLATEST DEAL TYPE
Developer of a genetic fingerprint detection technology. The company develops a technology that enables diagnostic devices to detect genetic and antibiotic resistance and facilitate treatment of bacterial infections.